loader
Please Wait
Applying Filters...

Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    Qualit-E-SpeakPharma-Insert
    X

    Information, Expiry & Status of FDA Orange Book Patents covering 10307376

    U.S. Patents

    Filters Filter
    ×
    FILTER DATA :

    filter

    NALPROPION

    filter

    10307376

    filter

    Blank

    filter

    Blank

    filter

    2027-11-08

    FILTER DATA FILTER DATA

    NALPROPION

    Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    Post An Enquiry Post An Enquiry

    Virtual Booth Virtual Booth

    BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE

    Contact the Supplier

    Supporting Information : Click here to upload a PDF

    10307376
    2027-11-08
    U-1585
    200063
    USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE
    1

    PharmaCompass >>

    First
    Previous
    Next
    Last
    Contact us
    to update this info

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search